| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23a4e0c875bf1ac2b8a3b76517de6c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc905cbef116a1ec61d12125af9427f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
| filingDate |
1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb17ed7284842286723ffd25f9eee8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28da3aeee1fce2738bf4ce7a7155cedd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9885b39e6693b4056b0c73daa72c3c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a2a3d9ab7ff35d1020eb1771462600f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6895478bd96473364c3d579d8a3ee759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca525eb8799f174fffcd2b08350c0a4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efe281aea8b4c324f7babb7977e5755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24663a370da12d2f7ba3601713cecea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f77a8a6fb90510c38d90730657cdfef |
| publicationDate |
1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5578636-A |
| titleOfInvention |
Polythiophene anti-tumor agents |
| abstract |
Novel polythiophene compounds useful as anti-tumor agents are described. Preferred compounds of the formula: <IMAGE> wherein n is 0-2 and R2 and R3 are optionally substituted 2-thienyl or 3-thienyl have been found to exhibit selective cytotoxic activity against transformed human cells. Pharmaceutical compositions containing the described polythiophene compounds are expected to exhibit good chemotherapeutic activity against slow growing tumors based on tumor cell line assays. A method for treating patients having tumors utilizing the disclosed polythiophene compounds is also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6620804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5994394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6894039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9823269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005203077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005064415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7161013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0866066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007197493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5741811-A |
| priorityDate |
1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |